12:00 AM
 | 
Aug 04, 2011
 |  BC Innovations  |  Distillery Therapeutics

Indication: Autoimmune disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information
Autoimmune disease
Autoimmune; multiple sclerosis (MS) CD3; CC chemokine receptor 6 (CCR6; CD196); chemokine CC...

Read the full 199 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >